⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)

Official Title: Multicentric, Randomized, Placebo Controlled and Double-blind Study to Evaluate the Efficacy and Safety of Antithrombotic Prophylaxis With Bemiparin (3,500 UI/Day) in Cancer Patients With a Central Venous Catheter (CVC)(BECAT)

Study ID: NCT00311896

Interventions

Bemiparin
Placebo

Study Description

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of the subcutaneous administration for 45 days of Bemiparin (3,500 UI/day) in cancer patients with a CVC, to prevent CVC-related deep venous thrombosis (CVC-DVT)

Detailed Description: Venous thromboembolism (VTE) is a common complication in patients with cancer principally in association with central vein catheters (CVC). The clinical benefit of antithrombotic prophylaxis for CVC-related VTE in cancer patients remains unclear.The aim of this study is to evaluate the efficacy and safety of the administration of Bemiparin in cancer patients with a central venous catheter (CVC). This study is designed as a multicenter, randomized, double-blind, placebo-controlled study. On the day of CVC insertion, eligible patients are randomly assigned to receive subcutaneously either bemiparin (3,500 UI/day) or placebo by using preloaded syringes for 45 days. The primary efficacy endpoint will be the combined incidence during the double blind treatment period of Clinical or symptomatic CVC-DVT verified objectively (Doppler ultrasonography or phlebography)and subclinical or asymptomatic CVC-DVT confirmed by elective bilateral Doppler ultrasonography performed 45±5 days after randomization.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Arad County Hospital, Arad, , Romania

Cenral Emergency Clinical Military H., Bucharest, , Romania

Sf Maria Clinical Hospital, Bucharest, , Romania

Oncology Institute Cuj-Napoca, Cluj-Napoca, , Romania

University "CF" Clinical Hospital, Cluj-Napoca, , Romania

Filantropia District Hospital, Craiova, , Romania

Oncology Medical Center, Iasi, Iasi, , Romania

District Emergency Clinical Hospital, Targu-Mures, , Romania

Hospital General de Alicante, Alicante, , Spain

Hospital Germans Trias i Pujol, Barcelona, , Spain

Hospital Santa Creu i Sant Pau, Barcelona, , Spain

Hospital Clínico San Carlos-Madrid., Madrid, , Spain

Hospital General Universitario Gregorio Marañón, Madrid, , Spain

Hospital Morales Meseguer, Murcia, , Spain

Clínica Universitaria de Navarra, Pamplona, , Spain

Complejo Hospitalario de Donostia, San Sebastian, , Spain

Instituto Valenciano de Oncología, Valencia, , Spain

Hospital Universitario Doctor Peset, Valencia, , Spain

Hospital Clinico Universitario Lozano Blesa, Zaragoza, , Spain

Contact Details

Name: Eduardo Rocha, MD

Affiliation: Clinica Universitaria de Navarra

Role: STUDY_CHAIR

Name: Ramon Lecumberri, MD

Affiliation: Clinica Universitaria de Navarra

Role: PRINCIPAL_INVESTIGATOR

Name: Vicente Vicente, MD

Affiliation: Hospital Morales Meseguer

Role: PRINCIPAL_INVESTIGATOR

Name: Pascual Marco, MD

Affiliation: Hospital General Universitario de Alicante

Role: PRINCIPAL_INVESTIGATOR

Name: José Mateo, MD

Affiliation: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Role: PRINCIPAL_INVESTIGATOR

Name: Albert Font, MD

Affiliation: Germans Trias i Pujol Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Carmen Arratibel, MD

Affiliation: Complejo Hospitalario de Donostia

Role: PRINCIPAL_INVESTIGATOR

Name: Francisco J. Capote, MD

Affiliation: Hospital Universitario Puerta del Mar

Role: PRINCIPAL_INVESTIGATOR

Name: Miguel Angel De gregorio Ariza, MD

Affiliation: Hospital Clinico Universitario Lozano Blesa-Zaragoza

Role: PRINCIPAL_INVESTIGATOR

Name: Isabel Picón Roig, MD

Affiliation: Instituto Valenciano de Oncología

Role: PRINCIPAL_INVESTIGATOR

Name: Ricardo González Del Val Subirats, MD

Affiliation: Hospital General Universitario Gregorio Marañón

Role: PRINCIPAL_INVESTIGATOR

Name: Carlos Bosh Roig, MD

Affiliation: Hospital Universitario Doctor Peset

Role: PRINCIPAL_INVESTIGATOR

Name: Pedro Pérez-Segura, MD

Affiliation: Hospital Clínico San Carlos-Madrid.

Role: PRINCIPAL_INVESTIGATOR

Name: Vicente Alberola, MD

Affiliation: Hospital Arnau de Vilanova de Valencia

Role: PRINCIPAL_INVESTIGATOR

Name: César Rodríguez Sánchez, MD

Affiliation: Hospital Clínico de Salamanca

Role: PRINCIPAL_INVESTIGATOR

Name: Ignacio Alberca Silva, MD

Affiliation: Hospital Clínico de Salamanca

Role: PRINCIPAL_INVESTIGATOR

Name: Javier García Frade, MD

Affiliation: Hospital del Río Hortega

Role: PRINCIPAL_INVESTIGATOR

Name: Carmen Sedano, MD

Affiliation: Hospital Marqués de Valdecilla

Role: PRINCIPAL_INVESTIGATOR

Name: Natividad Gómez, MD

Affiliation: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Role: PRINCIPAL_INVESTIGATOR

Name: Amalia Velasco, MD

Affiliation: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Role: PRINCIPAL_INVESTIGATOR

Name: Carmen Rodríguez Pinto, MD

Affiliation: Hospital Universitario Central de Asturias

Role: PRINCIPAL_INVESTIGATOR

Name: Mihai Ciochinaru, MD

Affiliation: Cenral Emergency Clinical Military H.

Role: PRINCIPAL_INVESTIGATOR

Name: Cornelia Toganel, MD

Affiliation: District Emergency Clinical Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Csaba Bela Szekely, MD

Affiliation: Arad District Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Mihaela Danciulescu, MD

Affiliation: Filantropia District Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Constantin Volovat, MD

Affiliation: Oncology Medical Center Iasi

Role: PRINCIPAL_INVESTIGATOR

Name: Mircea Cazacu, Prof.

Affiliation: University "CF" Clinical Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Eliade Ciuleanu, MD

Affiliation: Oncology Institute Cuj-Napoca

Role: PRINCIPAL_INVESTIGATOR

Name: Florin Bacanu, md

Affiliation: Sf Maria Clinical Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: